487 related articles for article (PubMed ID: 30277628)
1. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
Zou X; Luo Y; Li Z; Hu Y; Li H; Tang H; Shen Y; Hu D; Kamel IR
J Magn Reson Imaging; 2019 Apr; 49(4):975-983. PubMed ID: 30277628
[TBL] [Abstract][Full Text] [Related]
2. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
[TBL] [Abstract][Full Text] [Related]
3. Volumetric quantitative histogram analysis using diffusion-weighted magnetic resonance imaging to differentiate HCC from other primary liver cancers.
Lewis S; Peti S; Hectors SJ; King M; Rosen A; Kamath A; Putra J; Thung S; Taouli B
Abdom Radiol (NY); 2019 Mar; 44(3):912-922. PubMed ID: 30712136
[TBL] [Abstract][Full Text] [Related]
4. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
[TBL] [Abstract][Full Text] [Related]
5. Role of Intravoxel Incoherent Motion in Discriminating Hepatitis B Virus-Related Intrahepatic Mass-Forming Cholangiocarcinoma from Hepatocellular Carcinoma Based on Liver Imaging Reporting and Data System v2018.
Shao S; Shan Q; Zheng N; Wang B; Wang J
Cancer Biother Radiopharm; 2019 Oct; 34(8):511-518. PubMed ID: 31314589
[No Abstract] [Full Text] [Related]
6. The value of Gd-BOPTA- enhanced MRIs and DWI in the diagnosis of intrahepatic mass-forming cholangiocarcinoma.
Xu CC; Tang YF; Ruan XZ; Huang QL; Sun L; Li J
Neoplasma; 2017; 64(6):945-953. PubMed ID: 28895422
[TBL] [Abstract][Full Text] [Related]
7. Value of perfusion parameters histogram analysis of triphasic CT in differentiating intrahepatic mass forming cholangiocarcinoma from hepatocellular carcinoma.
Zhao F; Pang G; Li X; Yang S; Zhong H
Sci Rep; 2021 Nov; 11(1):23163. PubMed ID: 34848818
[TBL] [Abstract][Full Text] [Related]
8. Intravoxel incoherent motion diffusion-weighted imaging to differentiate hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Peng J; Zheng J; Yang C; Wang R; Zhou Y; Tao YY; Gong XQ; Wang WC; Zhang XM; Yang L
Sci Rep; 2020 May; 10(1):7717. PubMed ID: 32382050
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
10. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
Kim SS; Kim SH; Song KD; Choi SY; Heo NH
J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
[TBL] [Abstract][Full Text] [Related]
11. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
Zheng W; Huang H; She D; Xiong M; Chen X; Lin X; Cao D
Abdom Radiol (NY); 2022 Mar; 47(3):957-968. PubMed ID: 34964069
[TBL] [Abstract][Full Text] [Related]
12. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.
Wu H; Liang Y; Wang Z; Tan C; Yang R; Wei X; Jiang X
Acta Radiol; 2023 Mar; 64(3):926-935. PubMed ID: 35898164
[TBL] [Abstract][Full Text] [Related]
13. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
[TBL] [Abstract][Full Text] [Related]
14. Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index.
Hu XX; Yang ZX; Liang HY; Ding Y; Grimm R; Fu CX; Liu H; Yan X; Ji Y; Zeng MS; Rao SX
J Magn Reson Imaging; 2017 Aug; 46(2):383-392. PubMed ID: 27862582
[TBL] [Abstract][Full Text] [Related]
15. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
[TBL] [Abstract][Full Text] [Related]
16. Whole-lesion histogram analysis metrics of the apparent diffusion coefficient: a correlation study with histological grade of hepatocellular carcinoma.
Xu YS; Liu HF; Xi DL; Li JK; Liu Z; Yan RF; Lei JQ
Abdom Radiol (NY); 2019 Sep; 44(9):3089-3098. PubMed ID: 31256226
[TBL] [Abstract][Full Text] [Related]
17. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
18. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
Li X; Zhang K; Shi Y; Wang F; Meng X
J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient-based histogram analysis differentiates histological subtypes of periampullary adenocarcinoma.
Lu JY; Yu H; Zou XL; Li Z; Hu XM; Shen YQ; Hu DY
World J Gastroenterol; 2019 Oct; 25(40):6116-6128. PubMed ID: 31686767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
